2017 annual financial data
Inhibikase Therapeutics 2017 Net margin
Direct answer
Net margin was -21.16%.
Operating income was -405,130 USD and net income was -436,075 USD.
Operating cash flow was -126,391 USD.
Get free Inhibikase Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 2,060,937 USD
- Operating income
- -405,130 USD
- Net income
- -436,075 USD
- Operating cash flow
- -126,391 USD
Explore related company data
View all 2017 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all Inhibikase Therapeutics financial years